Pantheon hands off Cinven stakes

The Fourth Cinven Fund raised €6.58bn in 2006 and exited allergy testing company Phadia for $3.52bn in 2011.

To view this content you must sign in:

Not yet registered? Join today to access Secondaries Investor’s industry insights and updates.